Related Experiment Video

Updated: Jun 7, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Adherence to antiretroviral therapy in pediatric patients with human immunodeficiency virus (HIV-1)

Gail Burack1, Sunanda Gaur, Roseann Marone

  • 1Division of Allergy, Immunology and Infectious Diseases, New Brunswick, NJ, USA. burackgd@umdnj.edu

Journal of Pediatric Nursing
|November 2, 2010
PubMed

Insights

Accurate HIV treatment adherence monitoring is crucial. Combining caregiver reports, pharmacy refills, and appointment data offers a more reliable prediction of viral load suppression in pediatric HIV-1 patients.

Area of Science:

  • Infectious Diseases
  • Pediatric Medicine
  • Public Health

Background:

  • Effective management of HIV-1 infection relies on accurate assessment of treatment adherence to prevent resistant mutations, treatment failure, and disease progression.
  • Current methods for measuring HIV treatment adherence lack consistent accuracy, posing challenges in clinical practice.
  • Viral load suppression is a key indicator of successful HIV treatment outcomes.

Purpose of the Study:

  • To evaluate the association between three common adherence measures (caregiver reports, pharmacy refill data, appointment maintenance) and viral load suppression in pediatric HIV-1 patients.
  • To determine if a combined approach of adherence measures improves prediction of treatment success compared to individual measures.
  • To identify reliable methods for assessing treatment adherence in pediatric populations with HIV-1.

Main Methods:

  • Retrospective analysis of data from pediatric patients with HIV-1 infection.
  • Evaluation of three adherence measures: caregiver reports, pharmacy refill records, and appointment adherence.
  • Statistical analysis to assess the association between each adherence measure and viral load suppression.

Main Results:

  • No single adherence measure (caregiver reports, pharmacy refills, or appointment maintenance) showed a significant association with viral load suppression individually.
  • A significant prediction of treatment adherence was achieved when all three measures (caregiver reports, pharmacy refills, and appointment maintenance) were in agreement.
  • This suggests a synergistic effect of combining multiple adherence assessment tools.

Conclusions:

  • Individual measures of HIV treatment adherence are insufficient for accurately predicting viral load suppression in pediatric patients.
  • A comprehensive approach combining caregiver reports, pharmacy refill data, and appointment maintenance offers a more reliable method for assessing adherence.
  • Improved adherence monitoring strategies are essential for optimizing HIV treatment outcomes in children.

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...